Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries FDA approves Keytruda as adjuvant treatment for kidney cancer By: FOXNews.com November 18, 2021 at 19:04 PM EST The cancer immunotherapy drug Keytruda, was approved Thursday by the FDA Read More >> Related Stocks: Fancamp Exploration Ltd Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
FDA approves Keytruda as adjuvant treatment for kidney cancer By: FOXNews.com November 18, 2021 at 19:04 PM EST The cancer immunotherapy drug Keytruda, was approved Thursday by the FDA Read More >> Related Stocks: Fancamp Exploration Ltd